Sharpe ratio is not yet available for MPMCX. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar mutual funds
The table compares BNY Mellon Mid Cap Multi-Strategy Fund's Sharpe Ratio with other mutual funds in the Mid Cap Growth Equities category across multiple time periods, showing how MPMCX's risk-adjusted performance compares to similar funds.
Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jun 26, 2026.
| Symbol | Name | 1Y Sharpe Ratio | 5Y Sharpe Ratio | 10Y Sharpe Ratio | All Time Sharpe Ratio |
|---|---|---|---|---|---|
| NEEIX | Needham Growth Fund Institutional Class | 2.92 | |||
| NEEGX | Needham Growth Fund | 2.89 | |||
| VHCOX | Vanguard Capital Opportunity Fund Investor Shares | 2.70 | |||
| TAAGX | Timothy Plan Aggressive Growth Fund | 2.57 | |||
| POAGX | PrimeCap Odyssey Aggressive Growth Fund | 2.45 | |||
| MGOYX | Victory Munder Mid-Cap Core Growth Fund | 1.97 | |||
| CTIGX | Calamos Timpani SMID Growth Fund | 1.82 | |||
| ETILX | Eventide Gilead Class I | 1.80 | |||
| ETGLX | Eventide Gilead Fund | 1.79 | |||
| SSMGX | SIT Small Cap Growth Fund | 1.78 | |||
| MPMCX | BNY Mellon Mid Cap Multi-Strategy Fund | — |
Loading charts...
How does MPMCX fit in your portfolio?
Add your other holdings to see your portfolio's Sharpe Ratio and find out.
Analyze Your Portfolio